Target intelligence / Profile preview

SAP30-binding protein (SAP30BP)

Target
SAP30BP
Molecular classification
Other, Splicing cofactor, Transcription regulator-associated protein
01

Overview

SAP30-binding protein (SAP30BP) is a nuclear protein in humans that serves as an essential cofactor in RNA splicing and transcriptional repression. SAP30BP interacts tightly with CDK11 and cyclins L1/L2, functioning as a critical activator of CDK11 kinase activity and thereby regulating global pre-mRNA splicing[1]. It is also a key cofactor of RBM17 (SPF45), guiding its recruitment to active spliceosomes—particularly for the splicing of a subset of short introns with truncated polypyrimidine tracts, where it promotes assembly of the spliceosome independently of the canonical U2AF2–U2AF1 heterodimer[2][4]. Beyond splicing, SAP30BP can promote histone deacetylase activity, resulting in epigenetic modification through H3 deacetylation[3]. While not generally classified as a therapeutic target (receptor, enzyme, transporter), SAP30BP is essential for RNA processing and cell cycle regulation, which implicates it in diseases such as cancer, although no targeted drugs or biomarker applications are currently reported[1][2][3][4].

Other names
HCNGPHTRGHTRPTranscriptional regulator protein HCNGPSAP30BPSAP30-binding protein
02

Biological functions

Regulation of pre-mRNA splicingModulation of transcriptionPromotion of histone deacetylation (via recruitment/promotion of histone deacetylase activity)
03

Disease associations

Cancer (through its critical functions in RNA splicing and interaction with CDK11 and cyclins, related to cell cycle control)Other (broadly through gene expression regulation)

Beyond the preview

Go deeper on SAP30-binding protein (SAP30BP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SAP30-binding protein (SAP30BP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call